Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

[Aluminium hydroxide and its use].

Kinget R, Straetmans K.

J Pharm Belg. 2008 Mar;63(1):4-6. French. No abstract available.

PMID:
18479075
2.

[A new approach for preparing gels containing NSAIDs].

Kinget R.

J Pharm Belg. 2008 Mar;63(1):1-3. French. No abstract available.

PMID:
18479074
3.

[Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].

Stassen T, Piette M, Kinget R, Delattre L.

J Pharm Belg. 2006;61(1):1-10. French. No abstract available.

PMID:
16669341
4.

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.

Ugwoke MI, Agu RU, Verbeke N, Kinget R.

Adv Drug Deliv Rev. 2005 Nov 3;57(11):1640-65. Epub 2005 Sep 21. Review.

PMID:
16182408
5.

Mucosal response in African catfish after administration of Vibrio anguillarum O2 antigens via different routes.

Vervarcke S, Ollevier F, Kinget R, Michoel A.

Fish Shellfish Immunol. 2005 Feb;18(2):125-33.

PMID:
15475309
6.

Intravaginal gels as drug delivery systems.

Justin-Temu M, Damian F, Kinget R, Van Den Mooter G.

J Womens Health (Larchmt). 2004 Sep;13(7):834-44. Review.

PMID:
15385078
7.

Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium.

Agu RU, Vu Dang H, Jorissen M, Kinget R, Verbeke N.

Peptides. 2004 Apr;25(4):563-9.

PMID:
15165710
8.
9.

Intravenous versus subcutaneous injections of apomorphine in rabbits: a pharmacokinetic paradox.

Ugwoke MI, Agu RU, Kinget R, Verbeke N.

Boll Chim Farm. 2003 Oct;142(8):315-8.

PMID:
15040458
10.

In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved.

Agu R, Dang HV, Jorissen M, Willems T, Vandoninck S, Van Lint J, Vandenheede JV, Kinget R, Verbeke N.

Pharm Res. 2003 Aug;20(8):1125-32.

PMID:
12948008
11.

Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium.

Remigius UA, Jorissen M, Willems T, Kinget R, Verbeke N.

Eur J Pharm Biopharm. 2003 May;55(3):283-9.

PMID:
12754002
12.

Characterization of methacrylated inulin hydrogels designed for colon targeting: in vitro release of BSA.

Van den Mooter G, Vervoort L, Kinget R.

Pharm Res. 2003 Feb;20(2):303-7.

PMID:
12636172
13.

Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions.

Van Nijlen T, Brennan K, Van den Mooter G, Blaton N, Kinget R, Augustijns P.

Int J Pharm. 2003 Mar 26;254(2):173-81.

PMID:
12623193
14.

Development of a lag time coating for drug-layered fish feed pellets.

Vervarcke S, Ollevier F, Kinget R, Michoel A.

Pharm Dev Technol. 2002 Nov;7(4):471-80.

PMID:
12503528
15.

Enhanced anaerobic degradation of polymeric azo compounds by Escherichia coli in the presence of low-molecular-weight redox mediators.

Rau J, Maris B, Kinget R, Samyn C, Van Den Mooter G, Stolz A.

J Pharm Pharmacol. 2002 Nov;54(11):1471-9.

PMID:
12495549
16.

Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.

Verheyen S, Blaton N, Kinget R, Van den Mooter G.

Int J Pharm. 2002 Dec 5;249(1-2):45-58.

PMID:
12433433
17.

Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30.

Damian F, Blaton N, Kinget R, Van den Mooter G.

Int J Pharm. 2002 Sep 5;244(1-2):87-98.

PMID:
12204568
18.

Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures.

van Gelder J, Deferme S, Naesens L, De Clercq E, van den Mooter G, Kinget R, Augustijns P.

Drug Metab Dispos. 2002 Aug;30(8):924-30.

PMID:
12124311
19.

Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium.

Agu RU, Vu Dang H, Jorissen M, Willems T, Kinget R, Verbeke N.

Int J Pharm. 2002 Apr 26;237(1-2):179-91.

PMID:
11955816
20.

Polysaccharides as excipients for colon-specific coatings. Permeability and swelling properties of casted films.

Cavalcanti OA, Van den Mooter G, Caramico-Soares I, Kinget R.

Drug Dev Ind Pharm. 2002;28(2):157-64.

PMID:
11926360
21.

Influence of the composition of in-vitro azo-reducing systems on the degradation kinetics of the model compound amaranth.

Maris B, Verheyden L, Samyn C, Augustijns P, Kinget R, Van den Mooter G.

J Pharm Pharmacol. 2002 Feb;54(2):197-203.

PMID:
11848283
22.

Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781.

Deferme S, Van Gelder J, Ingels F, Van den Mooter G, De Buck S, Balzarini J, Naesens L, De Clercq E, Kinget R, Augustijns P.

Int J Pharm. 2002 Mar 2;234(1-2):113-9.

PMID:
11839442
23.
24.

The lung as a route for systemic delivery of therapeutic proteins and peptides.

Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N.

Respir Res. 2001;2(4):198-209. Epub 2001 Apr 12. Review.

25.

Determination of partial solubility parameters of five benzodiazepines in individual solvents.

Verheyen S, Augustijns P, Kinget R, Van den Mooter G.

Int J Pharm. 2001 Oct 9;228(1-2):199-207.

PMID:
11576782
26.

Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30).

Damian F, Blaton N, Desseyn H, Clou K, Augustijns P, Naesens L, Balzarini J, Kinget R, Van den Mooter G.

J Pharm Pharmacol. 2001 Aug;53(8):1109-16.

PMID:
11518020
27.

The biopharmaceutical aspects of nasal mucoadhesive drug delivery.

Ugwoke MI, Verbeke N, Kinget R.

J Pharm Pharmacol. 2001 Jan;53(1):3-21. Review.

PMID:
11206189
28.

New bis(SATE) prodrug of AZT 5'-monophosphate: in vitro anti-HIV activity, stability, and potential oral absorption.

Shafiee M, Deferme S, Villard AL, Egron D, Gosselin G, Imbach JL, Lioux T, Pompon A, Varray S, Aubertin AM, Van Den Mooter G, Kinget R, PĂ©rigaud C, Augustijns P.

J Pharm Sci. 2001 Apr;90(4):448-63.

PMID:
11170035
29.

Characterization of glassy itraconazole: a comparative study of its molecular mobility below T(g) with that of structural analogues using MTDSC.

Six K, Verreck G, Peeters J, Augustijns P, Kinget R, Van den Mooter G.

Int J Pharm. 2001 Feb 1;213(1-2):163-73.

PMID:
11165104
30.

Synthesis and characterisation of inulin-azo hydrogels designed for colon targeting.

Maris B, Verheyden L, Van Reeth K, Samyn C, Augustijns P, Kinget R, Van den Mooter G.

Int J Pharm. 2001 Feb 1;213(1-2):143-52.

PMID:
11165102
31.

Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.

Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R.

Eur J Pharm Sci. 2001 Jan;12(3):261-9.

PMID:
11113645
32.

Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism.

Van Gelder J, Deferme S, Annaert P, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P.

Drug Metab Dispos. 2000 Dec;28(12):1394-6.

PMID:
11095573
33.

Species-dependent and site-specific intestinal metabolism of ester prodrugs.

Van Gelder J, Shafiee M, De Clercq E, Penninckx F, Van den Mooter G, Kinget R, Augustijns P.

Int J Pharm. 2000 Sep 15;205(1-2):93-100.

PMID:
11000545
34.
35.

Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p((R)) and carboxymethylcellulose.

Ugwoke MI, Agu RU, Vanbilloen H, Baetens J, Augustijns P, Verbeke N, Mortelmans L, Verbruggen A, Kinget R, Bormans G.

J Control Release. 2000 Aug 10;68(2):207-14.

PMID:
10925129
36.

Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems.

Ikechukwu Ugwoke M, Kaufmann G, Verbeke N, Kinget R.

Int J Pharm. 2000 Jul 20;202(1-2):125-31.

PMID:
10915935
37.

In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.

Annaert P, Tukker JJ, van Gelder J, Naesens L, de Clercq E, van Den Mooter G, Kinget R, Augustijns P.

J Pharm Sci. 2000 Aug;89(8):1054-62.

PMID:
10906729
38.

Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14.

Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P, Van den Mooter G.

Eur J Pharm Sci. 2000;10(4):311-22.

PMID:
10838021
39.
40.

Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits.

Ugwoke MI, Exaud S, Van Den Mooter G, Verbeke N, Kinget R.

Eur J Pharm Sci. 1999 Dec;9(2):213-9.

PMID:
10620734
41.

Safety assessment of selected cyclodextrins - effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis.

Uchenna Agu R, Jorissen M, Willems T, Van den Mooter G, Kinget R, Verbeke N, Augustijns P.

Int J Pharm. 2000 Jan 5;193(2):219-26.

PMID:
10606785
42.

Effects of pharmaceutical compounds on ciliary beating in human nasal epithelial cells: a comparative study of cell culture models.

Agu RU, Jorissen M, Willems T, Van den Mooter G, Kinget R, Augustijns P.

Pharm Res. 1999 Sep;16(9):1380-5.

PMID:
10496653
43.

Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA.

Van Gelder J, Witvrouw M, Pannecouque C, Henson G, Bridger G, Naesens L, De Clercq E, Annaert P, Shafiee M, Van den Mooter G, Kinget R, Augustijns P.

Int J Pharm. 1999 Sep 20;186(2):127-36.

PMID:
10486430
44.
45.

Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.

Van Gelder J, Annaert P, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P.

Pharm Res. 1999 Jul;16(7):1035-40.

PMID:
10450927
46.

In vitro biodegradation study of acetyl and methyl inulins by Bifidobacteria and inulinase.

Damian F, Van den Mooter G, Samyn C, Kinget R.

Eur J Pharm Biopharm. 1999 May;47(3):275-82.

PMID:
10382112
47.

Nasal mucoadhesive delivery systems of the anti-parkinsonian drug, apomorphine: influence of drug-loading on in vitro and in vivo release in rabbits.

Ikechukwu Ugwoke M, Sam E, Van Den Mooter G, Verbeke N, Kinget R.

Int J Pharm. 1999 Apr 20;181(1):125-38.

PMID:
10370209
48.

Inulin hydrogels as carriers for colonic drug targeting. Rheological characterization of the hydrogel formation and the hydrogel network.

Vervoort L, Vinckier I, Moldenaers P, Van den Mooter G, Augustijns P, Kinget R.

J Pharm Sci. 1999 Feb;88(2):209-14.

PMID:
9950640
49.

Colonic drug targeting.

Kinget R, Kalala W, Vervoort L, van den Mooter G.

J Drug Target. 1998;6(2):129-49. Review.

PMID:
9886237
50.

Stability of UC-781, in intestinal mucosal homogenates of the rat, rabbit, and pig.

Van den Mooter G, Stas G, Damian F, Naesens L, Balzarini J, Kinget R, Augustijns P.

Pharm Res. 1998 Nov;15(11):1799-802. No abstract available.

PMID:
9834007

Supplemental Content

Loading ...
Support Center